Breach of Contract for a Branded Drug
Cornerstone Research and an affiliated expert analyzed the impact on a branded drug's value when a pharmaceutical company interrupted the supply and promotion of the drug.
Section 337 Unfair Import Investigation of Medical Devices
Cornerstone Research worked with a healthcare and competition expert in a patent infringement matter before the ITC.
United States of America ex rel. Susan Ruscher et al. v. Omnicare Inc. et al.
The U.S. District Court for the Southern District of Texas, Houston Division, granted summary judgment for the defendant in this case involving healthcare payment and billing practices.
Medical Device Patents
In a case involving patents related to a medical device, counsel for a leading healthcare company retained Dr. Michael Keeley and Cornerstone Research.
In re Actiq Sales and Marketing Practices Litigation
Cornerstone Research worked with three experts to address class certification and damages issues.
Cornerstone Research Coauthors Antitrust Amicus Curiae Brief for U.S. Third Circuit
The filing details economic considerations relevant to determining the appropriate scope of the U.S. Supreme Court’s 2013 decision in FTC v. Actavis.
Cornerstone Research Coauthors Antitrust Amicus Brief for Supreme Court
Filing Details Economic Evidence Against Using a Presumption of Illegality for Reverse Payment Settlements of Pharmaceutical Patent Infringement Suits
Boston Scientific Corp. et al. v. Cordis Corp.
Counsel for Boston Scientific retained Mary Woodford, a senior advisor at Cornerstone Research, to provide damages analysis and testimony in the May 2011 damages trial.
In re Northfield Laboratories, Inc., Securities Litigation
Counsel for the defendants retained Cornerstone Research and Professor Paul Gompers of Harvard Business School to analyze economic issues pertinent to class certification in this matter.
In re Boston Scientific Corporation Securities Litigation
This Rule 10b-5 case involved allegations that the company withheld material information about alleged faults with a medical device that it eventually recalled.
The exclusive licensee and the owners of a portfolio of patents related to certain medical devices alleged one of the licensee’s leading competitors had infringed one of the patents in…
How can we help you?
If you are looking for additional case experience examples, contact us.